What Brings Blood Sugar Down? Insulin to Diet

What brings blood sugar down depends on the cause of the elevation, the type of diabetes involved and how urgently action is needed. Insulin is the most potent agent, but physical activity, dietary choices and prescribed oral medicines all play important roles in day-to-day glucose management. For people with type 2 diabetes or prediabetes, consistent lifestyle habits are often as important as medication. This article explains the main options available, how they work, when to use them and when high blood sugar requires urgent medical attention rather than self-management.

What actually brings blood sugar down quickly?

Insulin is the most effective agent for rapidly lowering blood sugar, while moderate physical activity can also help, though ketones must be checked before exercising if glucose is markedly elevated.

Insulin is the most effective agent for bringing blood sugar down quickly, acting by enabling cells to absorb glucose from the bloodstream and reducing hepatic glucose output.^[2][12] For people without diabetes, the pancreas releases insulin automatically in response to rising blood glucose. For those with type 1 diabetes or advanced type 2 diabetes, injected insulin is the primary treatment.

In a non-emergency context, physical activity can also lower blood glucose relatively quickly, as working muscles take up glucose independently of insulin during moderate exercise.^[1][23] However, exercise is not appropriate in all situations. If blood glucose is markedly elevated, particularly in people with type 1 diabetes or during illness, ketones should be checked using a blood or urine ketone testing kit before exercising. If ketones are moderate or high, exercise should be avoided and medical advice sought promptly, as exercising with raised ketones can worsen the situation.^[22][2] People who are unsure about their ketone levels or what action to take should contact their diabetes team or call NHS 111.

People taking insulin or sulfonylureas should also be aware that exercise can increase the risk of hypoglycaemia (low blood sugar) during or after activity. It is advisable to monitor blood glucose before, during and after exercise, and to carry fast-acting carbohydrate (such as glucose tablets or a sugary drink) in case blood sugar drops too low.

It is important to distinguish between managing a mildly elevated reading and treating a medical emergency. Mild to moderate hyperglycaemia in a person with known diabetes can often be addressed through the measures described in the sections below, alongside any prescribed medication. However, severely elevated blood sugar, particularly when accompanied by symptoms such as vomiting, rapid breathing or confusion, requires prompt medical assessment rather than self-management at home.

For people managing type 2 diabetes, blood glucose does not usually need to come down within minutes. Consistent daily habits, including medication adherence, dietary choices and physical activity, are what sustain glucose control over time. Short-term spikes after meals are normal and are generally managed by the body's own insulin response or by prescribed medicines. Understanding the difference between a transient post-meal rise and persistently elevated fasting glucose helps people make informed decisions about when to act and when to monitor.

How do lifestyle changes help lower blood sugar levels?

Regular physical activity and a balanced diet are the lifestyle changes with the strongest evidence, improving insulin sensitivity and supporting glycaemic control in type 2 diabetes and prediabetes.

Regular physical activity and a balanced diet are the two lifestyle changes with the strongest evidence for lowering blood sugar levels in people with type 2 diabetes or prediabetes. NICE guidance on type 2 diabetes (NG28) recommends structured education, dietary advice and increased physical activity as core components of initial management, before or alongside medication.^[3][4] Exercise improves insulin sensitivity, meaning the body's cells respond more effectively to the insulin already present, which reduces circulating glucose.

Aerobic activity such as brisk walking, cycling or swimming is particularly well studied. The UK Chief Medical Officers' Physical Activity Guidelines recommend at least 150 minutes of moderate-intensity activity per week for adults, and this target is reflected in NICE NG28.^[5][6] Resistance training also contributes to improved glucose metabolism by increasing muscle mass, which acts as a major site of glucose uptake. Breaking up prolonged sitting with short bouts of movement has been shown to blunt post-meal glucose rises.

Weight management plays a significant role for people who are overweight. Even a modest reduction in body weight, in the region of 5 to 10 per cent, can meaningfully improve glycaemic control.^[3][8] The DiRECT trial (published in The Lancet) demonstrated that substantial weight loss through a structured low-calorie programme can lead to remission of type 2 diabetes in some people.^[8] The NHS Diabetes Prevention Programme is a separate initiative aimed at people identified as being at high risk of developing type 2 diabetes (prediabetes); it supports lifestyle change to reduce the likelihood of progression rather than to achieve remission of established diabetes.

Reducing alcohol intake and stopping smoking also support better glucose regulation, as both can impair insulin sensitivity and complicate diabetes management. A GP or diabetes specialist nurse can refer patients to structured lifestyle programmes available through the NHS.

Which medicines does the NHS use to reduce blood sugar?

Metformin is the NHS first-line treatment for type 2 diabetes, with SGLT-2 inhibitors, GLP-1 receptor agonists, sulfonylureas and insulin added according to individual clinical need.

The NHS uses a range of medicines to reduce blood sugar in people with type 2 diabetes, with metformin remaining the first-line treatment recommended by NICE (NG28) for most adults at diagnosis, provided it is tolerated and not contraindicated.^[3][4] Metformin works primarily by reducing glucose production in the liver and improving insulin sensitivity in peripheral tissues.^[10][11] It is taken orally, is generally well tolerated, and carries a low risk of hypoglycaemia when used alone.

When metformin alone is insufficient, NICE guidance supports the addition of further agents, chosen according to individual clinical factors. These include:

• SGLT-2 inhibitors (such as dapagliflozin and empagliflozin), which cause the kidneys to excrete excess glucose in the urine and also offer cardiovascular and renal protective benefits, as recognised in NICE technology appraisals and NG28^[9][24]

• GLP-1 receptor agonists used for glycaemic control in type 2 diabetes, including injectable semaglutide (Ozempic), oral semaglutide (Rybelsus) and liraglutide (Victoza)

• DPP-4 inhibitors (such as sitagliptin), which prolong the action of natural incretin hormones

• Sulfonylureas (such as gliclazide), which stimulate the pancreas to produce more insulin

• Pioglitazone, a thiazolidinedione that improves insulin sensitivity in muscle and fat tissue

• Insulin, used when other treatments are insufficient to achieve target glucose levels

Note that semaglutide is also available as Wegovy (for weight management) and liraglutide as Saxenda (for weight management); these weight-management brands carry different licensed indications and are not the same products used for glycaemic control in type 2 diabetes.

Tirzepatide (Mounjaro), a dual GIP and GLP-1 receptor agonist, is authorised by the MHRA both for type 2 diabetes and for chronic weight management.^[14][15] Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, where tirzepatide is one option a prescriber may consider after assessment if it is clinically appropriate. All prescribing decisions are made by a qualified clinician based on individual circumstances, and local ICB commissioning policies determine NHS availability.

Are there foods or drinks that help bring blood sugar down?

No single food reliably lowers blood sugar like medication, but low-GI foods, dietary fibre, protein and healthy fats help moderate post-meal glucose rises.

No single food or drink reliably brings blood sugar down in the way that medication does, but certain dietary patterns and food choices are associated with lower post-meal glucose rises and better overall glycaemic control. Foods with a low glycaemic index (GI), such as pulses, non-starchy vegetables, wholegrains and most fruits, are digested more slowly and produce a more gradual rise in blood glucose compared with high-GI foods such as white bread, sugary drinks and processed snacks.^[17][18] The British Dietetic Association (BDA) provides patient-friendly guidance on low-GI eating, and the NHS also offers dietary advice for people managing diabetes.

Dietary fibre, found in vegetables, legumes, oats and wholegrain cereals, slows carbohydrate absorption and supports a more stable glucose response after eating.^[17][18] Protein and healthy fats, when eaten alongside carbohydrates, also moderate the speed at which glucose enters the bloodstream.

Water is the most appropriate drink for people managing blood sugar, as it contains no glucose or calories. Unsweetened tea and coffee are generally acceptable in moderate amounts. Drinks to limit or avoid include sugary soft drinks, fruit juices, energy drinks and alcohol, all of which can cause rapid rises in blood glucose or interfere with the liver's glucose regulation.

It is worth noting that no food or supplement should be used as a substitute for prescribed medication. People with diabetes who wish to make significant dietary changes should discuss these with their GP, diabetes nurse or a registered dietitian, as changes in diet can affect how medicines work and may require dose adjustments. Tailored dietary advice is particularly important for people with co-morbidities such as chronic kidney disease, where additional dietary restrictions may apply.

When should you seek urgent help for high blood sugar?

Call 999 or go to A&E immediately if high blood sugar is accompanied by rapid breathing, persistent vomiting, severe confusion or moderate to high ketones, as these suggest DKA or HHS.

You should call 999 or go to the nearest accident and emergency department immediately if high blood sugar is accompanied by symptoms that suggest diabetic ketoacidosis (DKA) or hyperosmolar hyperglycaemic state (HHS), both of which are life-threatening emergencies. Warning signs that require emergency care include:

• Rapid or laboured breathing, sometimes with a fruity or acetone smell on the breath (a sign of DKA)

• Persistent vomiting that prevents keeping fluids down

• Severe confusion, drowsiness or loss of consciousness

• Signs of severe dehydration, such as dry mouth, sunken eyes and inability to urinate

DKA occurs most commonly in people with type 1 diabetes but can also affect those with type 2 diabetes, particularly during illness, infection or when insulin is omitted.^[20][21] HHS tends to develop more gradually in people with type 2 diabetes and is associated with very high blood glucose levels and profound dehydration.

If blood glucose is elevated and you feel unwell, checking for ketones using a home blood or urine ketone testing kit is an important step. Moderate or large ketones alongside high blood glucose require urgent medical attention even if other symptoms are not yet severe. Diabetes UK provides guidance on ketone testing and sick-day rules, including advice on which medicines to adjust during illness.

People taking SGLT-2 inhibitors (such as dapagliflozin or empagliflozin) should be aware that these medicines are generally recommended to be withheld during acute illness, as they can be associated with DKA even when blood glucose is not markedly elevated.^[13][21] Your diabetes team or GP can advise on a personalised sick-day plan.

For blood glucose readings that are higher than your target range but you feel reasonably well, contact your GP or diabetes team for advice. If your surgery is closed, NHS 111 can provide guidance on whether you need to be seen urgently. People with diabetes are advised to have a clear sick-day management plan agreed with their clinical team, which sets out what to do with medication and monitoring during illness.

Suspected adverse effects from any diabetes medicine, including unexpected changes in blood glucose, should be reported to your prescriber. Side effects from licensed medicines can also be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Scientific References

1. Exercise regulation of glucose transport in skeletal muscle.
2. High blood sugar (hyperglycaemia).
3. Type 2 diabetes in adults: management (NG28).
4. Type 2 diabetes in adults: choosing, reviewing and stopping medicines — NG28 visual summary.
5. Physical activity guidelines: UK Chief Medical Officers' report.
6. UK Chief Medical Officers' physical activity guidelines (full text).
7. Physical activity guidelines for adults aged 19 to 64.
8. 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT).
9. Type 2 diabetes — Treatment summaries (BNF).
10. Metformin Effects on SHIP2, AMPKs and Gut Microbiota: Recent Updates on Pharmacology.
11. Metabolic Effects of Metformin in Humans.
12. AMPK activation: a therapeutic target for type 2 diabetes?.
13. SGLT2 inhibitors: updated advice on the risk of diabetic ketoacidosis.
14. MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss.
15. Tirzepatide — BNF/NICE.
16. Tirzepatide: a medicine to manage type 2 diabetes and obesity.
17. Glycaemic Index (GI) — British Dietetic Association.
18. Glycemic response and health: summary of a workshop.
19. Differential Modulation of Postprandial Glycemic, Incretin, and Satiety Responses by Low-Digestible Carbohydrates in Humans.
20. Biochemical profiles and precipitating factors of diabetic ketoacidosis among type 1 and type 2 diabetes patients.
21. Ketoacidosis with SGLT2 inhibitors in routine clinical practice of type 2 diabetes: Scandinavian cohort and nested case-control study.
22. Continuous ketone monitoring: Exciting implications for clinical practice.
23. AMPKγ3 Controls Muscle Glucose Uptake in Recovery From Exercise to Recapture Energy Stores.
24. Network and pairwise meta-analysis of the effects of novel hypoglycemic agents on cardiorenal outcomes in patients with type 2 diabetes and heart failure.
25. Renoprotective effects and safety of sodium-glucose cotransporter 2 inhibitors in diabetic chronic kidney disease: A systematic review and meta-analysis.

Frequently Asked Questions